Reliance Global Group, Inc. (EZRA)
NASDAQ: EZRA · Real-Time Price · USD
0.1620
-0.0080 (-4.71%)
May 11, 2026, 9:48 AM EDT - Market open
Reliance Global Group Revenue
Reliance Global Group had revenue of $3.80M in the quarter ending March 31, 2026, a decrease of -10.28%. This brings the company's revenue in the last twelve months to $12.00M, down -15.57% year-over-year. In the year 2025, Reliance Global Group had annual revenue of $12.43M, down -11.55%.
Revenue (ttm)
$12.00M
Revenue Growth
-15.57%
P/S Ratio
0.30
Revenue / Employee
$300,538
Employees
40
Market Cap
3.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.43M | -1.62M | -11.55% |
| Dec 31, 2024 | 14.05M | 322.60K | 2.35% |
| Dec 31, 2023 | 13.73M | 1.97M | 16.75% |
| Dec 31, 2022 | 11.76M | 2.05M | 21.13% |
| Dec 31, 2021 | 9.71M | 2.41M | 33.07% |
| Dec 31, 2020 | 7.30M | 2.85M | 63.95% |
| Dec 31, 2019 | 4.45M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SelectQuote | 1.64B |
| Crawford & Company | 1.26B |
| Crawford & Company | 1.26B |
| eHealth | 528.91M |
| Goosehead Insurance | 382.20M |
| GoHealth | 361.85M |
| TWFG, Inc. | 267.53M |
| Huize Holding | 226.22M |
EZRA News
- 3 days ago - Reliance Global Group Earnings Call Transcript: Q1 2026 - Transcripts
- 3 days ago - Reliance Global Group Reports First Quarter 2026 Results and Advances Scale51 Strategy Through Targeted Technology and Life Sciences Investments - GlobeNewsWire
- 4 days ago - Reliance Global Group Transcript: AGM 2026 - Transcripts
- 4 days ago - Reliance Global Group Schedules First Quarter 2026 Financial Results and Business Update Conference Call - GlobeNewsWire
- 6 days ago - Reliance Global Group Launches LifeSci Global, Its Dedicated Life Sciences Platform, Partnering with Proven Operators Scott Korman and David Turner to Build and Lead the Platform with Innervate Radiopharmaceuticals as the First Platform Investment - GlobeNewsWire
- 7 days ago - Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division - GlobeNewsWire
- 13 days ago - Reliance Global increases ownership in Enquantum to 29% - TheFly
- 13 days ago - Reliance Global Group Increases Ownership in Enquantum to 29% Following Achievement of Defined Technical and Commercial Milestones - GlobeNewsWire